Both stocks run through our valuation models. Here is how CM Hospitalar (VVEO3) and McKesson (MCK) compare, as of Aug 14, 2026.
As of Aug 14, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: CM Hospitalar trades at BRL 0.63 versus a fair value of BRL 0.42 (-34%), while McKesson trades at $857 versus $819 (-4%).
CM Hospitalar
VVEO3.SA · BRL · Health Care
-34%
upside to fair value
overvalued
PriceBRL 0.63
Fair ValueBRL 0.42
Quality54/100
McKesson
MCK · USD · Health Care
-4%
upside to fair value
fairly valued
Price$857
Fair Value$819
Quality66/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
CM HospitalarMcKesson
Valuation
9.5×P/E (TTM)21.0×
0.02×P/S (TTM)0.23×
0.09×P/B—
3.2×EV/EBITDA13.9×
—PEG1.57×
—Dividend yield0.4%
—Dividend per share$3.17
Profitability
0%Net margin1%
4%Operating margin2%
1%Return on equity—
4%Return on assets5%
Growth
2%Revenue growth (YoY)6%
9.8%Avg. growth/yr (3Y)13.4%
21.3%Avg. growth/yr (5Y)11.1%
Balance & size
1.26×Debt / equity—
$35MMarket cap$94B
mixedGrowth qualityhealthy
CM Hospitalar leads: 5 to 4 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
CM Hospitalarof which business quality 52 · market factors 14McKessonof which business quality 65 · market factors 64
ProfitabilityMargins and returns on capital today
37
49
Quality GrowthAre margins and returns improving?
69
65
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
100
76
Low VolatilityCalm price path (market factor)
44
83
MomentumPrice trend over the last 3–12 months (market factor)
0
51
52W MomentumDistance to the 52-week high (market factor)
3
64
Net IssuanceBuybacks instead of dilution
63
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
CM Hospitalar
DCF ModelsBRL 16.63
Earnings-BasedBRL 2.03
Dividend DiscountBRL 1.57
MultiplesBRL 8.62
Asset-BasedBRL 4.11
Growth DCFBRL 10.81
Economic ProfitBRL 4.88
Growth EarningsBRL 1.77
0 of 24 models see the stock below the current price.
McKesson
DCF Models$955
Earnings-Based$444
Dividend Discount$57.26
Multiples$848
Growth DCF$922
Economic Profit$497
Growth Earnings$708
11 of 23 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
CM Hospitalar
Bear BRL 0.19Fair Value BRL 0.42Bull BRL 0.63
BRL 0.63 = current price (white tick)
McKesson
Bear $605Fair Value $819Bull $1,034
$857 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
CM Hospitalar · Health Care
Quality score54 · above median
Fair value upside-34% · below median
McKesson · Health Care
Quality score66 · Top 25%
Fair value upside-4% · above median
Bottom line
As of Aug 14, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: CM Hospitalar trades at BRL 0.63 versus a fair value of BRL 0.42 (-34%), while McKesson trades at $857 versus $819 (-4%).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
